Vocal Fold Leukoplakia: Updates in Diagnosis and Management
	    		
		   		
		   			
		   		
	    	
    	 
    	10.22469/jkslp.2022.33.1.13
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Jeong-Yeon JI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Tack-Kyun KWON
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, Korea
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Review Article
 
        	
        	
            
            
            	- From:Journal of the Korean Society of Laryngology Phoniatrics and Logopedics
	            		
	            		 2022;33(1):13-19
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:Korean
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	 Vocal fold leukoplakia poses a challenge to otolaryngologists due to its various spectrum of pathologic diagnosis. The degree of dysplasia is associated with malignancy risk and the new 2017 WHO classification system changed from the 3-tier system to a 2-tier system consisting of low and high grades. Infections including candidiasis, cryptococcosis, and tuberculosis should also be included in the differential diagnosis. Efforts have been made to evaluate risks using endoscopic technologies such as narrow band imaging, and surgery is essential for histopathological diagnosis. Regarding management, it is important to make an accurate diagnosis and find a balance between oncologic safety and functional outcome.